EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Outcomes of Catheter Directed Thrombolysis for Early and Late Re-occlusions in Acute Lower Limb Ischemia

S Oukrich iD, S A N Doelare iD, A M Wiersema, A W J Hoksbergen, K K Yeung iD, V Jongkind iD

Journal of Endovascular Therapy · 2024

DOI: 10.1177/15266028241286830 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Endovascular Therapy, 2024. Verfasst von S Oukrich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC location Vrije Universiteit, Department of Surgery, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Ischemia, Thrombolytic Therapy, Lower Extremity, Peripheral Arterial Disease. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Acute lower limb ischemia (ALI) is a sudden decrease in arterial limb perfusion due to an arterial blockage, threatening limb and life. Catheter-directed thrombolysis (CDT) is a minimally invasive procedure to remove such obstructions. However, approximately one-third of patients endure a re-occlusion after successful CDT. This study aimed to investigate the short- and long-term outcomes of CDT for early (1 year) re-occlusions. Material and Methods: This retrospective multicenter study reviewed patients from 2 medical centers with an acute arterial re-occlusion of the lower limb after successful CDT between December 1996 and April 2021. The primary endpoints were angiographic success, defined as thrombus dissolution over 95% with outflow to at least 1 crural artery, and clinical success, defined as a score of ≥1 on the Rutherford scale for assessing changes in clinical status. Secondary endpoints included bleeding complications, patency, amputation, and mortality. Kaplan-Meier analyses were used to estimate patency, survival, and freedom from amputation.

Results

Seventy-seven cases were included, with 52 early re-occlusions (1 year). The median time to re-occlusion since the last CDT treatment was 4 months in the early re-occlusion group and 24 months in the late re-occlusion group. Angiographic success was achieved in 73% of early and 64% of late re-occlusions. Clinical success rates were 80.8% for the early and 80.0% of the late re-occlusion cases. Major bleeding occurred in 2% of the early and 8% of the late re-occlusion group. Patients were followed up until symptoms or signs of limb ischemia were resolved, with a median follow-up time of 15 months for the early and 22 months for the late re-occlusion group. During follow-up, secondary re-occlusions were observed in 59.6% of the early and 44% in the late group. Cumulative amputation rates at 1, 5, and 8 years were 36%, 36%, and 52% for early and 18%, 30%, and 30% for the late re-occlusions, respectively.

Conclusion

In our experience, CDT is an effective short-term revascularization strategy for the majority of patients with both early and late re-occlusions. Long-term results are limited by secondary re-occlusions and limb loss. Clinical Impact Catheter-directed thrombolysis (CDT) is a well-established treatment for acute lower limb ischemia (ALI). Re-occlusions after successful treatment are, however, observed in almost a third of the patients. Yet, the outcomes of CDT for re-occlusions for patients who were previously treated with CDT are not well known. This study showed that CDT is effective in achieving revascularization in cases of early and late re-occlusion after treatment for ALI, but the risk for further re-occlusions is high. Future studies should focus on maintaining patency after successful CDT for ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IschemiaThrombolytic TherapyLower ExtremityPeripheral Arterial DiseaseFibrinolytic AgentsCatheterization, PeripheralHumansRetrospective StudiesTime FactorsFemaleMaleAgedMiddle AgedVascular PatencyTreatment OutcomeLimb SalvageAmputation, SurgicalRecurrenceRisk FactorsAcute DiseaseAged, 80 and over

Stichwörter der Autor:innen

Acute lower limb ischemiaalteplasecatheter directed thrombolysislong-term outcomeperipheral arterial occlusive diseasere-occlusionthrombolytic therapyurokinase

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Amsterdam UMC location Vrije Universiteit, Department of Surgery, Amsterdam, the Netherlands.
  • Amsterdam Cardiovascular Sciences, Microcirculation, Amsterdam, the Netherlands.
  • Amsterdam Cardiovascular Sciences, Atherosclerosis & Ischemic Syndromes, Amsterdam, the Netherlands.
  • Dijklander Hospital, Department of Surgery, Hoorn, the Netherlands.

ORCID-Profile: S Oukrich, S A N Doelare, K K Yeung, V Jongkind

Zitieren

APA

Oukrich, S., Doelare, S. A. N., Wiersema, A. M., Hoksbergen, A. W. J., Yeung, K. K., & Jongkind, V. (2024). Outcomes of Catheter Directed Thrombolysis for Early and Late Re-occlusions in Acute Lower Limb Ischemia. Journal of Endovascular Therapy. https://doi.org/10.1177/15266028241286830

Vancouver

Oukrich S, Doelare SAN, Wiersema AM, Hoksbergen AWJ, Yeung KK, Jongkind V. Outcomes of Catheter Directed Thrombolysis for Early and Late Re-occlusions in Acute Lower Limb Ischemia. Journal of Endovascular Therapy. 2024. doi:10.1177/15266028241286830

BibTeX
@article{Oukrich2024,
  author = {Oukrich, S and Doelare, S A N and Wiersema, A M and Hoksbergen, A W J and Yeung, K K and Jongkind, V},
  title = {Outcomes of Catheter Directed Thrombolysis for Early and Late Re-occlusions in Acute Lower Limb Ischemia},
  journal = {Journal of Endovascular Therapy},
  year = {2024},
  doi = {10.1177/15266028241286830}
}
Kostenlos starten →